LITTLE FALLS, New Jersey,
Aug. 1, 2016 /PRNewswire/ --
CANTEL MEDICAL CORP. (NYSE: CMN) announced today the
appointment of Jorgen B. Hansen as
the Company's President and Chief Executive Officer, effective
today, consistent with the Company's long-term CEO succession plan.
Mr. Hansen also will become a member of the Board of Directors. Mr.
Hansen succeeds Andrew A. Krakauer,
who will serve as a Senior Advisor for the Company until
October 15, 2016.
Charles M. Diker, Cantel's
Chairman of the Board, stated, "We brought Jorgen Hansen to Cantel nearly four years ago.
He's a dynamic, experienced leader in the medical device industry
who has clearly demonstrated strong leadership and the vision
necessary to achieve our full potential. In addition to leading the
day-to-day operations for the Company, Jorgen played a key role in
the development of our strategic plan including our expansion in
international markets and the successful completion of 12
acquisitions. All of these accomplishments have reinforced our
confidence in Jorgen's ability to lead the Company as Chief
Executive Officer."
Mr. Diker added "I also would like to thank Andy Krakauer for his exceptional service to the
Company over the past 12 years. He has been an outstanding leader
who helped Cantel achieve exceptional success during his tenure.
His contributions and experience in the medical device industry
have been invaluable to the Company."
Mr. Hansen joined Cantel in November
2012 as EVP and COO, and was appointed to President and COO
in November 2014. He also served as
President and CEO of Cantel's Endoscopy business unit, the
Company's largest division, from November
2012 to July 2015. Prior to
joining Cantel, Mr. Hansen held leadership positions with
increasing responsibility in the global medical device industry. He
worked at ConvaTec from May 2009 -
November 2012, most recently as
Senior Vice President, Global Marketing, Business Development,
Science and Innovation. Mr. Hansen joined ConvaTec from Coloplast,
where he held various leadership roles over a 13-year period in
Asia and Europe, ranging from General Manager, Division
Head and Senior Vice President of Global Operations. He received a
Bachelor of Science Degree in Mechanical Engineering from Denmark
Technical University, and an International Commerce degree from the
Copenhagen Business School in Denmark.
"I am honored to be appointed as Cantel's CEO and lead this
exciting company and talented team," said Mr. Hansen. "I would like
to thank Mr. Diker and the Board for this opportunity, and as CEO,
I will continue to pursue Cantel's vision to be the global leader
in infection prevention. We will do this by executing on our
business priorities focused on new products, market expansion and
M&A, supported by continuous improvement."
About Cantel Medical
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, dialysate concentrates, hollow
fiber membrane filtration and separation products. Additionally, we
provide technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.